Cancer and COVID-19: unravelling the immunological interplay with a review of promising therapies against severe SARS-CoV-2 for cancer patients

Cancer patients, due to their immunocompromised status, are at an increased risk for severe SARS-CoV-2 infection. Since severe SARS-CoV-2 infection causes multiple organ damage through IL-6-mediated inflammation while stimulating hypoxia, and malignancy promotes hypoxia-induced cellular metabolic al...

Descripción completa

Detalles Bibliográficos
Autores principales: Leyfman, Yan, Emmanuel, Nancy, Menon, Gayathri P., Joshi, Muskan, Wilkerson, William B., Cappelli, Jared, Erick, Timothy K., Park, Chandler H., Sharma, Pushpa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10100631/
https://www.ncbi.nlm.nih.gov/pubmed/37055774
http://dx.doi.org/10.1186/s13045-023-01432-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10100631/
https://www.ncbi.nlm.nih.gov/pubmed/37055774
http://dx.doi.org/10.1186/s13045-023-01432-6

Ejemplares similares